OR WAIT null SECS
Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.
March 01, 2017
Mass spectrometry plays and important role in advancing on biologic drug development and manufacturing, but limitations still exist.
February 02, 2017
Drug manufacturers need to work closely with excipient suppliers to ensure supply chain safety.
Although limitations must be overcome, mass spectrometry is having a great impact on biologic development and manufacturing.
February 01, 2017
FDA issued approvals for less than half the number of new drugs in 2016 compared with 2015.
January 04, 2017
Alternatives to expensive palladium catalysts are gaining acceptance for commercial API synthesis.
January 02, 2017
As of mid-December, less than half the number of new drug approvals were issued by FDA in 2016 compared with 2015.